Cargando...
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles()
Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease symptoms are undefined and specific biomarkers are lacking, about 80% of patients present with advanced, inoperable tumors that represent a daunting chal...
Gardado en:
| Publicado en: | Transl Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Neoplasia Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486738/ https://ncbi.nlm.nih.gov/pubmed/26055177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.03.011 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|